Notice of Resolutions of the 88th Ordinary General Meeting of Shareholders

Dear Shareholders:

Sekisui Chemical Co., Ltd.(hereinafter "the Company") hereby informs you of the matters reported and the matters resolved at the 88th Ordinary General Meeting of Shareholders ("the Meeting") held today as follows.

Matters reported:

1.	The Reports on the Business Report, the Consolidated Accounting Documents and the Non-Consolidated Accounting Documents for the 88th Business Term (from April 1, 2009 to March 31, 2010).
2.	Report on the Results of the Audits of Consolidated Accounting Documents by the Accounting Auditor and the Board of Corporate Auditors.

Matters resolved:

1.	Appropriation of Retained Earnings The proposed appropriation of retained earnings has been approved at this meeting, and it was resolved to distribute the year-end dividend be 5 yen per share.
2.	Appointment of Nine (9) Directors As proposed, nine (9) Directors have been elected. The names of the Directors are as followings. Naotake Okubo Naofumi Negishi Takayoshi Matsunaga Yoshiyuki Takitani Ken Yoshida Teiji Kouge Hajime Kubo *Shigemi Tamura *Tohru Tsuji *Messrs. Tamura and Tsuji are outside Directors prescribed by Article 2, Item 15 of the Companies Act of Japan.
3.	Appointment of Two (2) Corporate Auditors As proposed, two (2) Corporate Auditors have been elected. The names of the Corporate Auditors are as followings. *Tadashi Kunihiro Shuichi Shino *Mr. Kunihiro is an outside Corporate Auditor prescribed by Article 2, Item 16 of the Companies Act of Japan.
4.	Issuance of Stock Acquisition Rights under the Stock Option Plan As proposed, it has been approved that the Company would issue stock acquisition rights to representative directors, certain directors and key employees of certain subsidiaries and affiliated companies of Sekisui Chemical Group, for the purpose of granting stock options, pursuant to the provisions of Articles 236, 238 and 239 of the Corporate Law, and that the Company would delegate the determination of the terms and conditions thereof to the Board of Directors of the Company.